-
[show abstract]
[hide abstract]
ABSTRACT: Several studies have demonstrated that gonadal hormones show significant effects on the brain and signaling pathways of effector organs/cells that respond to neurotransmitters. Since little information is available concerning the impact of male and female gonadal hormones on the renal and peripheral sympathetic system, the objective of this study was to further assess whether and how the renal content and plasma concentration of catecholamines are influenced by gender and the estrous cycle in rats. To achieve this, males Wistar rats were divided into 4 groups: (i) sham (i.e., control), (ii) gonadectomized, (iii) gonadectomized and nandrolone decanoate replacement at physiological levels or (iv) gonadectomized and nandrolone decanoate replacement at high levels. Female Wistar rats were divided into 6 groups: (i) ovariectomized (OVX), (ii) estrogen replacement at physiological levels and (iii) estrogen replacement at at high levels, (iv) progesterone replacement at physiological levels and (v) progesterone replacement at at high levels, and (vi) sham. The sham group was subdivided into four subgroups: (i) proestrus, (ii) estrus, (iii) metaestrus, and (iv) diestrus. Ten days after surgery, the animals were sacrificed and their plasma and renal catecholamine levels measured for intergroup comparisons. Gonadectomy led to an increase in the plasma catecholamine concentration in females, as well as in the renal catecholamine content of both male and female rats. Gonadectomized males also showed a lower level of plasma catecholamine than the controls. The urinary flow, and the fractional excretion of sodium and chloride were significantly increased in gonadectomized males and in the OVX group when compared with their respective sham groups.
Canadian Journal of Physiology and Pharmacology 01/2012; 90(1):75-82. · 1.95 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The role of renal nerve in excretion was investigated during acute obstructive apnea (OA) episodes in SHR. The animals (SHR and control, C) were presented for renal denervation (D; CD; SHRD) or undenervation (U; CU; SHRU). Tracheal catheterization was performed to induce OA via its total occlusion. Urine samples were collected every 2 min after 20 s of OA. Obstructive apnea resulted in bradycardia, hypotension, and induced elevations in the urinary measurements in SHRU, but not in CU. Conversely, the denervation increased in CD, but not in the SHRD. Urinary excretion was dependent of renal nerve in SHR during OA.
Clinical and Experimental Hypertension 01/2010; 32(8):555-9. · 1.07 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The gain of the volume-sensitive cardiopulmonary reflex (VSCR) is impaired in spontaneously hypertensive rats (SHR). Sensitivity of VSCR control of efferent renal sympathetic nerve activity (RSNA) in SHR is restored when cardiac hypertrophy and hypertension are reduced by enalapril treatment. The present study investigated which of these two parameters, cardiac hypertrophy or hypertension, has more influence on the impairment of VSCR control of RSNA in SHR. Rats (SHR or Wistar-Kyoto (WKY) rats) were treated with enalapril (10 mg/kg per day; SHRE and WKYE groups, respectively) or hydralazine (5 mg/kg per day; SHRH and WKYH groups, respectively) mixed in their food for 1 month. Control SHR and WKY rats were fed a normal diet. After the treatment regimen, the VSCR was evaluated by determining the decrease in RSNA elicited by acute isotonic saline volume expansion. Mean arterial pressure (MAP) was assessed via an intrafemural catheter and cardiac hypertrophy was determined by the left ventricular (LV) weight/bodyweight (BW) ratio. Afferent baroceptor nerve activity (BNA) was also evaluated during volume expansion to verify participation of the baroreflex. Volume expansion produced an attenuated renal sympathoinhibitory response in SHR compared with WKY rats. Enalapril treatment restored the volume expansion-induced decrease in RSNA in SHRE (-41 +/- 8%) compared with WKY rats (-44 +/- 3%). Although both enalapril and hydralazine treatment reduced MAP in SHR (P < 0.01; 126 +/- 5, 133 +/- 6 and 160 +/- 6 mmHg in SHRE, SHRH and SHR, respectively), hydralazine did not restore the sensitivity of VSCR control of RSNA in SHRH. Spontaneously hypertensive rats with established hypertension had a higher LV/BW ratio compared with WKY rats (3.22 +/- 0.14 vs 1.98 +/- 0.06 mg/g, respectively; P < 0.01). Enalapril reduced the LV/BW ratio in SHRE (2.30 +/- 0.07 mg/g; P < 0.01). Although hydralazine reduced LV hypertrophy, there was a weaker reduction in SHRH (2.68 +/- 0.04 mg/g; P < 0.05) compared with SHRE. There was no statistically significant difference among the WKY rat, WKYE and WKYH groups (P > 0.05). There was no change in afferent BNA during volume expansion in normal or hypertensive animals. Taken together, these results indicate that the impairment of VSCR control of RSNA in the SHR model of hypertension correlates better with the magnitude of cardiac hypertrophy than the level of arterial pressure.
Clinical and Experimental Pharmacology and Physiology 10/2008; 35(9):1104-8. · 1.85 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: We investigated the influence of short-term treatment with supraphysiological doses of an anabolic-androgenic steroid on the Bezold-Jarisch reflex (BJR) control of heart rate (HR) and whether this treatment induced cardiac hypertrophy and anabolic effects in rats.
Male rats were treated with nandrolone decanoate (10 mg/kg(-1) body weight/4 weeks; DECA) or vehicle control (CON). After 4 weeks of treatment, BJR was evaluated by bradycardia responses that were elicited by serotonin administration (2-32 microg/kg(-1)). Mean arterial pressure (MAP) was assessed and cardiac hypertrophy was determined by the left ventricle weight/body weight (LVW/BW) ratio. Histological analyses of LV and the measurement of the total body protein content of the animals were performed.
Nandrolone decanoate (ND) treatment had no effect on the MAP (CON=105+/-5; DECA=110+/-3 mmHg). However, the mean basal HR of DECA animals was significantly lower than that of control animals (CON = 381+/-14; DECA=324+/-12 bpm; p<0.01). ND did not change the sensitivity of the BJR. The LVW/BW ratio indicated significant hypertrophy of the LV in DECA animals (CON=1.76+/-0.04; DECA=2.0+/-0.04 mg/g; p<0.01). Histological and morphometrical analyses demonstrate that there is also modest myocyte hypertrophy (CON=14.5+/-1.5; DECA=20.0 +/- 0.9 myocyte nuclei/field; p<0.05). However, the Masson-trichromic-stained samples showed an enhancement of collagen deposits on the LV matrix.
We concluded that 4 weeks ND treatment induced an anabolic effect and the beginnings of LV remodeling, mainly due to excessive collagen deposition in the cardiac extracellular matrix. However, the treatment did not influence BJR control of bradycardia, an effect that could be explained by an enhanced efferent vagal tonus in DECA animals.
Archives of Medical Research 02/2008; 39(1):27-32. · 1.88 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Central 5-HT2A receptors have been implicated in central volume control by activating a central angiotensinergic pathway to cause the release of vasopressin. Interestingly, to induce DOCA-salt hypertension in rats vasopressin release is required. Thus the present experiments were carried out to determine whether continuous blockade of these receptors over 20 days, with the non-selective 5-HT2 receptor antagonist mianserin would prevent the development of deoxycorticosterone acetate (DOCA)-salt hypertension. Mianserin, given i.c.v. 90 or 60 microg twice daily for 20 days prevented the development of hypertension in conscious rats receiving DOCA-salt but did not affect blood pressure in rats on salt alone. Further, the dose of 30 microg given i.c.v. twice daily had no effect nor did the vehicle, polyethylene glycol (PEG), on the development of the hypertension. Mianserin 90 microg twice daily i.c.v. was also shown to prevent the increase in fluid intake, urinary flow and sodium excretion caused by DOCA-salt treatment. These data indicate that this action of mianserin is not due to an intrinsic hypotensive action but an action which involves interference with the mechanism by which DOCA-salt treatment causes hypertension. Thus the data overall support the view that to induce hypertension with DOCA-salt a central 5-HT-containing pathway needs to be activated, which then activates 5-HT2 receptors to cause the release of vasopressin which has previously been shown to be responsible for the initiation of DOCA-salt treatment hypertension.
European Journal of Pharmacology 09/2005; 518(2-3):152-7. · 2.52 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The identification of populational levels of maximum oxygen uptake (VO(2max)) is an aid to studies that propose to relate physical fitness to cardiovascular risk, and also for prescribing exercise and analyzing the effects of training. To date, there is no information with which this parameter can be classified in samples of adolescents from the Brazilian population. This study is, therefore, the first to propose the determination of mean VO(2max) levels in a sample of the Brazilian population.
A sample of 380 schoolchildren (177 boys and 203 girls, aged 10 to 14 years) was selected at random from public schools in Vitória, ES. After anthropometric assessment they underwent cardiopulmonary exercise testing, VO(2max) was measured directly and results were classified according to quintiles calculated from the study sample.
The mean VO(2max) values observed ranged from 42.95 to 49.55 mL x kg(-1) x min(-1) for boys and from 36.76 to 38.29 mL x kg(-1) x min(-1) for girls.
This paper proposes mean VO(2max) ranges as a classification parameter for cardiorespiratory fitness, in addition to contributing to a definition of normal values for the Brazilian population. This classification will also be of use for establishing cutoff points in future studies.
Jornal de Pediatria 82(6):426-30. · 1.01 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Maximum oxygen uptake is emerging as the measure of preference for expressing cardiorespiratory fitness for the purposes of surveys of physical activity, due to its greater objectivity and lower propensity to errors. Studies indicate that this measure is better correlated with cardiovascular diseases. This paper proposes to relate cardiovascular risk factors in adolescents with their level of cardiorespiratory fitness.
The study enrolled 380 schoolchildren, 177 boys and 203 girls (10 to 14 years old), who were divided into two groups according to their cardiorespiratory fitness. Anthropometric assessment was carried out, hemodynamic measurements (arterial pressure and heart rate) were taken, cardiopulmonary exercise testing was performed and biochemical tests were run (triglycerides, total and partial cholesterol).
Among the boys, significant differences were observed between boys defined as "weak" and those classed as "not weak" in terms of baseline heart rate, maximum oxygen uptake, body mass index and triglycerides. Among the girls, significant differences were detected between baseline heart rates, maximum oxygen uptake and body mass indices. In both sexes, the group classified as "weak" exhibited a significantly greater number of overweight individuals that the "not weak" group (chi2 = 25.242; p = 0.000; chi2 = 12.683; p = 0.000, for boys and girls, respectively). A significant association between cardiorespiratory fitness and triglycerides (chi2 = 3.944; p = 0.047) was observed among the boys only.
A low level of cardiorespiratory fitness appears to have a negative influence on cardiovascular risk factors among adolescents, especially with relation to overweight in both sexes and to biochemical profile in the male sex, providing evidence of the need for early preventative interventions.
Jornal de Pediatria 83(5):429-35. · 1.01 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Central 5-HT2A receptors have been implicated in central volume control by activating a central angiotensinergic pathway to cause the release of vasopressin. Interestingly, to induce DOCA–salt hypertension in rats vasopressin release is required. Thus the present experiments were carried out to determine whether continuous blockade of these receptors over 20 days, with the non-selective 5-HT2 receptor antagonist mianserin would prevent the development of deoxycorticosterone acetate (DOCA)–salt hypertension. Mianserin, given i.c.v. 90 or 60 μg twice daily for 20 days prevented the development of hypertension in conscious rats receiving DOCA–salt but did not affect blood pressure in rats on salt alone. Further, the dose of 30 μg given i.c.v. twice daily had no effect nor did the vehicle, polyethylene glycol (PEG), on the development of the hypertension. Mianserin 90 μg twice daily i.c.v. was also shown to prevent the increase in fluid intake, urinary flow and sodium excretion caused by DOCA–salt treatment. These data indicate that this action of mianserin is not due to an intrinsic hypotensive action but an action which involves interference with the mechanism by which DOCA–salt treatment causes hypertension. Thus the data overall support the view that to induce hypertension with DOCA–salt a central 5-HT-containing pathway needs to be activated, which then activates 5-HT2 receptors to cause the release of vasopressin which has previously been shown to be responsible for the initiation of DOCA–salt treatment hypertension.
European Journal of Pharmacology.
